TargetMol

L-Lactic acid

Product Code:
 
TAR-T4845
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T4845-500mg500mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4845-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4845-1g1g£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Lactic acid is an organic acid. It is a chiral molecule, consisting of two optical isomers, L-lactic acid and D-lactic acid, with the L-isomer being the most common in living organisms. Lactic acid plays a role in several biochemical processes and is produced in the muscles during intense activity.
CAS:
79-33-4
Formula:
C3H6O3
Molecular Weight:
90.078
Pathway:
Metabolism; Microbiology/Virology
Purity:
0.9865
SMILES:
C[C@H](O)C(O)=O
Target:
Endogenous Metabolite; Antibacterial; Antibiotic

References

Hirschhaeuser F , Sattler U G A , Mueller-Klieser W . Lactate: A Metabolic Key Player in Cancer[J]. Cancer Research, 2011, 71(22):6921-6925. Hoffmann G F , Meieraugenstein W , St?ckler, S, et al. Physiology and pathophysiology of organic acids in cerebrospinal fluid[J]. Journal of Inherited Metabolic Disease, 1993, 16(4):648-669. Walenta S , Schroeder T , Mueller-Klieser W . Lactate in Solid Malignant Tumors: Potential Basis of a Metabolic Classification in Clinical Oncology[J]. Current Medicinal Chemistry, 2004, 11(16):2195-2204. Choi SY, et al.Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite? J Pathol. 2013 Aug;230(4):350-5. doi: 10.12002/path.4218.